Branded drugs are more expensive because they’re newer, generally groundbreaking, and often for conditions that are difficult to treat. However, after a certain period of time, these same innovative medicines become a generic.

The difference between our approach and that of many other companies is that when a medicine becomes a generic, we still assume responsibility.

​​​​​​​Rather than focus on just what’s in development, we continue to closely monitor the quality, safety, and reliability of our generic medicines.